Delivery Order SPE2DR25D9127-SPE2DR26FCZB2
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $20,592.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 unit vials of Kcentra. The award was issued on November 24, 2025, with an ultimate completion date of December 16, 2025, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,901.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 units of Kcentra. The award, issued on October 29, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $9,639.84 to DMS Pharmaceutical Group Inc. for 1,000 unit vials of Kcentra on November 13, 2025, with an ultimate completion date of December 5, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without any set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The...
- The Defense Logistics Agency awarded a $7,296.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 unit vials of Kcentra. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, carries no set-aside designation. This award represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $20,592.96 to DMS Pharmaceutical Group Inc. for 1,000 unit vials of Kcentra on December 9, 2025, with an ultimate completion date of December 31, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract structure with no set-aside designation. The company will deliver the product to Park Ridge, Illinois,...
- The Defense Logistics Agency awarded a delivery order valued at $3,213.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 1,000 units of Kcentra. The contract is firm fixed-price with no set-aside designation and is scheduled for ultimate completion on November 24, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order valued at $13,546.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 500-unit vials of Kcentra. The delivery order, issued on June 18, 2025, with an ultimate completion date of July 11, 2025, employs firm fixed-price pricing with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,714.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the specialty pharmaceutical product Kcentra. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,107.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is to provide Kcentra 500unit 1s, a specialized pharmaceutical product, with a period of performance through December 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,213.76 by the Defense Logistics Agency on August 26, 2025. The contract calls for the delivery of 1,000 unit vials of Kcentra, a prothrombin complex concentrate used to reverse warfarin anticoagulation. The delivery order carries an ultimate completion date of September 17, 2025, and was awarded without a set-aside...
- SPE2DR25D9127Indefinite Delivery Contract
- SPE2DR25D9127-SPE2DR26FCZB2Delivery Order
The Defense Logistics Agency awarded a $27,457.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 1,000 unit vials of Kcentra. The delivery order, issued on December 10, 2025, with an ultimate completion date of January 2, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award falls under DMS Pharmaceutical Group's recently established Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring pharmaceutical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with substantial contracting activity from the Defense Logistics Agency's Medical Supply Chain division. The company's IDC under PPV-G GEN V, valued at up to $499,999,999 through December 31, 2036, authorizes the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, vaccines, and medical consumables. The current delivery order for Kcentra reflects the company's ongoing role in supporting Department of Defense healthcare operations and demonstrates its established performance capability in fulfilling specialized pharmaceutical requirements for military medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.5k | 12/9/25 |